Pfizer Escapes Aussie Antitrust Watchdog's Lipitor Case
Australia's High Court has rejected the nation's competition watchdog's efforts to revive an antitrust case accusing Pfizer of abusing its market power to maintain control of the Australian generic market for...To view the full article, register now.
Already a subscriber? Click here to view full article